β-Lactamase-non-producing ampicillin-resistant Haemophilus influenzae is acquiring multidrug resistance

Shogo Yamada1, Shoji Seyama1, Takeaki Wajima1

  • 1Department of Microbiology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.

Abstract

Insights

Antimicrobial resistance in Haemophilus influenzae is rising in Japan. Beta-lactamase-non-producing ampicillin-resistant H. influenzae (BLNAR) strains are increasing and show multidrug resistance, indicating a need for monitoring.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Emergence of antimicrobial-resistant Haemophilus influenzae strains in Japan.
  • Need to investigate H. influenzae non-susceptibility to beta-lactams and non-beta-lactams.

Purpose of the Study:

  • To investigate the prevalence and characteristics of H. influenzae non-susceptibility to beta-lactams and non-beta-lactams.
  • To identify trends in antimicrobial resistance patterns.

Main Methods:

  • Analysis of 260 H. influenzae isolates from 2013-2016.
  • Antimicrobial susceptibility testing using minimum inhibitory concentration (MIC).
  • Genetic and statistical analysis of resistant isolates.

Main Results:

  • Significant increase in beta-lactamase-non-producing ampicillin-resistant H. influenzae (BLNAR) strains, exceeding 50% of isolates by 2014.
  • Significant rise in quinolone-low-susceptibility isolates (P<0.05).
  • Identification of multidrug-resistant H. influenzae (MDRHI) isolates exhibiting resistance to multiple antibiotic classes, including beta-lactams, quinolones, and macrolides. Low non-beta-lactam susceptibility associated with BLNAR.

Conclusions:

  • BLNAR strains are increasing and demonstrate a tendency towards multidrug resistance.
  • Emergence of multidrug-resistant H. influenzae (MDRHI) in Japan.
  • Importance of monitoring BLNAR strain proportions to prevent the spread of MDRHI.